Ticker: HEPA

HEPION PHARMACEUTICALS, INC. (NASDAQ: HEPA) Snapshot - what's happening inside: management has pivoted from drug development to diagnostics, sold its Rencofilstat patent assets, completed a $9.0M registered offering in Jan‑2025, in‑licensed CE‑marked diagnostics from New Day (May‑9‑2025) and reco...